Allergic rhinitis and inflammatory airway disease: Interactions within the unified airspace

American Journal of Rhinology and Allergy

Volumn 24, Issue 4, 2010, Pages 249-254

  Marple, Bradley F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adenoidal hypertrophy; Allergic inflammation; Allergic rhinitis; Allergic rhinitis comorbidities; Asthma; Inflammatory airway disease; Intranasal corticosteroids; Nasal polyps; Rhinosinusitis; Upper and lower airway connection

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CD34 ANTIBODY; CORTICOSTEROID; DEXAMETHASONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLUTICASONE PROPIONATE; HISTAMINE H4 RECEPTOR; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MOMETASONE FUROATE; PLACEBO; TIXOCORTOL; VASCULAR CELL ADHESION MOLECULE 1;

ADENOIDAL HYPERTROPHY; ADJUVANT THERAPY; ALLERGIC RHINITIS; ASTHMA; BASOPHIL; CHEMOTAXIS; CLINICAL TRIAL; COMORBIDITY; COUGHING; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; EOSINOPHIL; HEALTH CARE COST; HUMAN; HYPERTROPHY; IMMUNE RESPONSE; IMMUNOTHERAPY; INFLAMMATION; LEUKOCYTE MIGRATION; LUNG; MACROPHAGE; MAST CELL; MEDIATOR; MEDLINE; MIDDLE EAR; NASOPHARYNX; NEUTROPHIL; NOSE OBSTRUCTION; NOSE POLYP; NOSE PROVOCATION TEST; PARANASAL SINUS; PATHOPHYSIOLOGY; RESPIRATORY TRACT ALLERGY; REVIEW; RHINORRHEA; RHINOSCLEROMA; RHINOSINUSITIS; SECRETORY OTITIS MEDIA; SLEEP APNEA SYNDROME; SNORING; T LYMPHOCYTE; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHI; CELL COMMUNICATION; CLINICAL TRIALS AS TOPIC; COMORBIDITY; HUMANS; INFLAMMATION; PARANASAL SINUSES; PREVALENCE; RESPIRATORY SYSTEM; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; RISK FACTORS;

EID: 77955639677     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2010.24.3499     Document Type: Review

References (87)

1. Krouse JH. The unified airway - Conceptual framework. Otolaryngol Clin North Am 41:257-266, v, 2008.
2. Braunstahl G-J, and Hellings PW. Nasobronchial interaction mechanisms in allergic airways disease. Curr Opin Otolaryngol Head Neck Surg 14:176-182, 2006.
3. Corren J. Allergic rhinitis and asthma: How important is the link? J Allergy Clin Immunol 99:S781-S786, 1997.
4. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(suppl 86):8-160, 2008.
5. Linneberg A, Henrik Nielsen N, Frølund L, et al. The link between allergic rhinitis and allergic asthma: A prospective population-based study. The Copenhagen Allergy Study. Allergy 57:1048-1052, 2002.
6. Thomas M. Allergic rhinitis: Evidence for impact on asthma. BMC Pulm Med 6(suppl 1):S4, 2006.
7. Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: A longitudinal population-based study. Lancet 372:1049-1057, 2008.
8. Corren J, Manning BE, Thompson SF, et al. Rhinitis therapy and the prevention of hospital care for asthma: A case-control study. J Allergy Clin Immunol 113:415-419, 2004.
9. Joe SA, and Thakkar K. Chronic rhinosinusitis and asthma. Otolaryngol Clin North Am 41:297-309, vi, 2008.
10. Gelincik A, Büyüköztürk S, Aslan I, et al. Allergic vs nonallergic rhinitis: Which is more predisposing to chronic rhinosinusitis? Ann Allergy Asthma Immunol 101:18-22, 2008.
11. Gutman M, Torres A, Keen KJ, and Houser SM. Prevalence of allergy in patients with chronic rhinosinusitis. Otolaryngol Head Neck Surg 130:545-552, 2004.
12. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 129(suppl):S1-S32, 2003.
13. Ponikau JU, Sherris DA, Kephart GM, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: Is the histopathology similar to asthma? J Allergy Clin Immunol 112:877-882, 2003.
14. Luong A, and Roland PS. The link between allergic rhinitis and chronic otitis media with effusion in atopic patients. Otolaryngol Clin North Am 41:311-323, vi, 2008.
15. Nguyen LHP, Manoukian JJ, Sobol SE, et al. Similar allergic inflammation in the middle ear and the upper airway: Evidence linking otitis media with effusion to the united airways concept. J Allergy Clin Immunol 114:1110-1115, 2004.
16. Hurst DS, and Venge P. Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy. Allergy 55:435-441, 2000.
17. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol 122(suppl):S1-S84, 2008.
18. Stool SE, Berg AO, Berman S, et al. Otitis media with effusion in young children. Clinical Practice Guideline, No. 12, AHCPR Publication No. 94-0622. Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, Rockville, MD, July 1994.
19. Tomonaga K, Kurono Y, and Mogi G. The role of nasal allergy in otitis media with effusion: A clinical study. Acta Otolaryngol (Stockh) 458(suppl):41-47, 1988.
20. Alles R, Parikh A, Hawk L, et al. The prevalence of atopic disorders in children with chronic otitis media with effusion. Pediatr Allergy Immunol 12:102-106, 2001.
21. Mygind N, Dahl R, and Bachert C. Nasal polyposis, eosinophil dominated inflammation, and allergy. Thorax 55(suppl 2):S79-S83, 2000.
22. Kuhn FA, and Swain R Jr. Allergic fungal sinusitis: Diagnosis and treatment. Curr Opin Otolaryngol Head Neck Surg. 11:1-5, 2003.
23. Farooque SP, and Lee TH. Aspirin-sensitive respiratory disease. Annu Rev Physiol. 71:465-487, 2009.
24. Awad OG, Fasano MB, Lee JH, et al. Asthma outcomes after endoscopic sinus surgery in aspirin-tolerant versus aspirin-induced asthmatic patients. Am J Rhinol 22:197-203, 2008.
25. Modrzynski M, and Zawisza E. An analysis of the incidence of adenoid hypertrophy in allergic children. Int J Pediatr Otorhinolaryngol 71:713-719, 2007.
26. Huang S-W, and Giannoni C. The risk of adenoid hypertrophy in children with allergic rhinitis. Ann Allergy Asthma Immunol 87:350-355, 2001.
27. Yildirim N, Sahan M, and Karslioglu Y. Adenoid hypertrophy in adults: Clinical and morphological characteristics. J Int Med Res 36:157-162, 2008.
28. Abdullah B, Hassan S, Sidek D, and Jaafar H. Adenoid mast cells and their role in the pathogenesis of otitis media with effusion. J Laryngol Otol 120:556-560, 2006.
29. Ahmad N, and Zacharek MA. Allergic rhinitis and rhinosinusitis. Otolaryngol Clin North Am 41:267-281, v, 2008.
30. Bascom R, Pipkorn U, Proud D, et al. Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: Effect of systemic corticosteroids and relationship to eosinophil influx. J Allergy Clin Immunol 84:338-346, 1989.
31. Bochner BS, and Schleimer RP. Mast cells, basophils, and eosinophils: Distinct but overlapping pathways for recruitment. Immunol Rev 179:5-15, 2001.
32. Eliashar R, and Levi-Schaffer F. The role of the eosinophil in nasal diseases. Curr Opin Otolaryngol Head Neck Surg 13:171-175, 2005.
33. Rosenberg HF, Phipps S, and Foster PS. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 119:1303-1310, 2007.
34. Wardlaw AJ. Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm. J Allergy Clin Immunol 104:917-926, 1999.
35. Chan KH, Abzug MJ, Coffinet L, et al. Chronic rhinosinusitis in young children differs from adults: A histopathology study. J Pediatr 144:206-212, 2004.
36. Ponikau JU, Sherris DA, Kephart GM, et al. Striking deposition of toxic eosinophil major basic protein in mucus: Implications for chronic rhinosinusitis. J Allergy Clin Immunol 116:362-369, 2005.
37. Iino Y, Nagamine H, Yabe T, and Matsutani S. Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma. Clin Exp Allergy 31:1135-1143, 2001.
38. Hurst DS, and Venge P. The presence of eosinophil cationic protein in middle ear effusion. Otolaryngol Head Neck Surg 108:711-722, 1993.
39. Hurst DS, Amin K, Sevéus L, and Venge P. Evidence of mast cell activity in the middle ears of children with otitis media with effusion. Laryngoscope 109:471-477, 1999.
40. Bachert C, Vignola AM, Gevaert P, et al. Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin North Am 24:19-43, 2004.
41. Bachert C, Wagenmann M, Hauser U, and Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 99:837-842, 1997.
42. Simon H-U, Yousefi S, Schranz C, et al. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 158:3902-3908, 1997.
43. Bachert C, Gevaert P, Holtappels G, et al. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 107:607-614, 2001.
44. Alobid I, Benítez P, Valero A, et al. The impact of atopy, sinus opacification, and nasal patency on quality of life in patients with severe nasal polyposis. Otolaryngol Head Neck Surg 134:609-612, 2006.
45. Braunstahl GJ. The unified immune system: Respiratory tract-nasobronchial interaction mechanisms in allergic airway disease. J Allergy Clin Immunol 115:142-148, 2005.
46. Beeh KM, Beier J, Kornmann O, et al. A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: Correlation with plasma interleukin-5. Clin Exp Allergy 33:475-482, 2003.
47. Corren J, Adinoff AD, and Irvin CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 89:611-618, 1992.
48. Braunstahl G-J, Overbeek SE, KleinJan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 107:469-476, 2001.
49. Braunstahl G-J, Overbeek SE, Fokkens WJ, et al. Segmental broncho-provocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 164:858-865, 2001.
50. Frieri M. Neuroimmunology and inflammation: Implications for therapy of allergic and autoimmune diseases. Ann Allergy Asthma Immunol 90(suppl 3):34-40, 2003.
51. Sarin S, Undem B, Sanico A, and Togias A. The role of the nervous system in rhinitis. J Allergy Clin Immunol 118:999-1014, 2006.
52. Naclerio RM, Pinto J, deTineo M, and Baroody FM. Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc 29:24-28, 2008.
53. Baroody FM, Mucha SM, deTineo M, and Naclerio RM. Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol 121:1126-1132, 2008.
54. Baroody FM, Ford S, Proud D, et al. Relationship between histamine and physiological changes during the early response to nasal antigen provocation. J Appl Physiol 86:659-668, 1999.
55. Wagenmann M, Baroody FM, Cheng C-C, et al. Bilateral increases in histamine after unilateral nasal allergen challenge. Am J Respir Crit Care Med 155:426-431, 1997.
56. Sheahan P, Walsh RM, Walsh MA, and Costello RW. Induction of nasal hyper-responsiveness by allergen challenge in allergic rhinitis: The role of afferent and efferent nerves. Clin Exp Allergy 35:45-51, 2005.
57. Thurmond RL, Gelfand EW, and Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: The search for new antihistamines. Nat Rev Drug Discov 7:41-53, 2008.
58. Van Ganse E, Kaufman L, Derde MP, et al. Effects of antihistamines in adult asthma: A meta-analysis of clinical trials. Eur Respir J 10:2216-2224, 1997.
59. Bousquet J, Demarteau N, Mullol J, et al. Costs associated with persistent allergic rhinitis are reduced by levocetirizine. Allergy 60:788-794, 2005.
60. Busse WW. The role of leukotrienes in asthma and allergic rhinitis. Clin Exp Allergy 26:868-879, 1996.
61. Stewart RA, Ram B, Hamilton G, et al. Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis. Otolaryngol Head Neck Surg 139:682-687, 2008.
62. Calderon MA, Alves B, Jacobson M, et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 1:CD001936, 2007.
63. Passalacqua G, and Durham SR. Allergic rhinitis and its impact on asthma update: Allergen immunotherapy. J Allergy Clin Immunol 119:881-891, 2007.
64. Nelson HS. Multiallergen immunotherapy for allergic rhinitis and asthma. J Allergy Clin Immunol 123:763-769, 2009.
65. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: Adult sinusitis. Otolaryngol Head Neck Surg 137(suppl):S1-S31, 2007.
66. Calamita Z, Saconato H, Bronhara Pela A, and Atallah AN. Efficacy of Sublingual immunotherapy in asthma. Systematic review of randomized clinical trials. Allergy 61:1162-1172, 2006.
67. Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in children. Meta analysis of randomized controlled trials. Ann Allergy Asthma Immunol 97:141-148, 2006.
68. Penagos M, Passalacqua G, Compalati E, et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 133:599-609, 2008.
69. Wilson DR, Torres L, and Durham SR. Sublingual immunotherapy for allergic rhinitis Allergy 60:4-12, 2005.
70. Bousquet P, Cox LS, Durham SR, et al. Sub-Lingual Immunotherapy: World Allergy Organization Position Paper 2009. World Allergy Organiz J 2:233-281, 2009.
71. Marple BF, Fornadley JA, Patel AA, et al, and the American Academy of Otolaryngic Allergy Working Group on Allergic Rhinitis. Keys to successful management of patients with allergic rhinitis: Focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg 136(suppl):S107-S124, 2007.
72. Mygind N, and Andersson M. Topical glucocorticosteroids in rhinitis: Clinical aspects. Acta Otolaryngol 126:1022-1029, 2006.
73. Naclerio RM, Adkinson NF Jr, Creticos PS, et al. Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol 92:717-721, 1993.
74. Marple BF. Targeting congestion in allergic rhinitis: The importance of intranasal corticosteroids. Allergy Asthma Proc 29:232-240, 2008.
75. Greenberger PA. Allergic rhinitis and asthma connection: Treatment implications. Allergy Asthma Proc 29:557-564, 2008.
76. Crystal-Peters J, Neslusan C, Crown WH, and Torres A. Treating allergic rhinitis in patients with comorbid asthma: The risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 109:57-62, 2002.
77. Adams RJ, Fuhlbrigge AL, Finkelstein JA, and Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 109:636-642, 2002.
78. Fokkens W, Lund V, and Mullol J, on behalf of the European Position Paper on Rhinosinusitis and Nasal Polyps Group. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007: A summary for otorhinolaryngologists. Rhinology 45:97-101, 2007.
79. Slavin RG, Spector SL, Bernstein IL, et al. The diagnosis and management of sinusitis: A practice parameter update. J Allergy Clin Immunol 116(suppl):S13-S47, 2005.
80. Williamson IG, Rumsby K, Benge S, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: A randomized controlled trial. JAMA 298:2487-2496, 2007.
81. Meltzer EO, Bachert C, and Staudinger H. Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 116:1289-1295, 2005.
82. Joe SA, Thambi R, and Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngol Head Neck Surg 139:340-347, 2008.
83. Kalish L, Arendts G, Sacks R, and Craig JC. Topical steroids in chronic rhinosinusitis without polyps: A systematic review and metaanalysis. Otolaryngol Head Neck Surg. 141:674-683, 2009.
84. Zhang L, Mendoza-Sassi RA, César JA, and Chadka NK. Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy. Cochrane Database Syst Rev 3:CD006286, 2008.
85. Thomas CL, Simpson S, Butler CC, and van der Voort J. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev 3:CD001935, 2006.
86. Tracy JM, Demain JG, Hoffman KM, and Goetz DW. Intranasal beclomethasone as an adjunct to treatment of chronic middle ear effusion. Ann Allergy Asthma Immunol 80:198-206, 1998.
87. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105:651-663, 2000.